Concern about records of fibrosing colonopathy study

Lancet

Volumn 357, Issue 9267, 2001, Pages 1526-1527

  Breckenridge, Alasdair ^a   Raine, June ^b  

^a Committee on Safety of Medicines ^*  (United Kingdom)

^b MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PANCREAS ENZYME; PANCREAS EXTRACT; PANCREOZYME;

ABDOMINAL SURGERY; COLON DISEASE; CYSTIC FIBROSIS; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; HUMAN; HYPOTHESIS; LETTER; PATHOLOGIST; PATHOLOGY; PRIORITY JOURNAL; SAMPLE; THEORY; CHEMICALLY INDUCED DISORDER; CHILD; COLON; DOSE RESPONSE; DRUG SURVEILLANCE PROGRAM; INTESTINE OBSTRUCTION; NOTE; SCIENTIFIC MISCONDUCT; UNITED KINGDOM;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; COLON; COLONIC DISEASES; CYSTIC FIBROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENGLAND; HUMANS; INTESTINAL OBSTRUCTION; PANCREATIC EXTRACTS; SCIENTIFIC MISCONDUCT;

EID: 0343773015     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(00)04676-6     Document Type: Letter

References (1)

1. Report of the Pancreatic Enzymes Working Party. MCA/CSM, May, 1995.